drugset / Trial / NCT00360464

A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases

NCT00360464

Phase 3 Completed 64 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the clinical efficacy and safety in patients with Acute Bronchitis or Secondary Infection of Chronic Respiratory Diseases receiving a dose of 2 g of azithromycin in the SR formulation.

Timeline

Start
2006-10
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 2 g

Indications